Soon after Ozempic hit the market in 2017, Novo Nordisk began to market the drug as a potential weight loss drug
Mutation Research/Genetic Toxicology and Environmental Mutagenesis (2008)
Tirzepatide Before diving deeper, it's essential to clarify the medications involved: Semaglutide: This is the active ingredient in three different brand-name medications from Novo Nordisk 2 : Wegovy: An injectable approved by the FDA specifically for chronic weight management in adults and adolescents aged 12 and older with obesity, or for adults who are overweight and have weight-related medical problems
This means tirzepatide may help some patients manage both blood sugar and weight when used under proper medical supervision
Always consult your healthcare provider before making changes to your medication, meals, or health routines
While mild gastrointestinal symptoms are common and expected during GLP-1 therapy, certain situations require prompt medical evaluation